Nav: Home

To slow malaria, cure mosquitoes with drug-treated bed nets

March 11, 2019

For decades, one of the strongest weapons against malaria has been a one-two punch: low-tech mosquito bed nets to physically block biting, treated with deadly insecticides to kill the mosquitoes.

With widespread use of this combination, malaria deaths have dropped significantly -- though nearly 445,000 people died from the disease in 2016 alone. But now the threat is again worsening, as the ever-adaptable pest has become resistant to insecticides.

Lauren Childs, an assistant professor of mathematics in the Virginia Tech College of Science, has joined with researchers from Harvard University's T.H. Chan School of Public Health, to develop a solution that could prevent or even reduce additional malaria deaths.

Childs is second author on a paper published recently in Nature. Researchers found that they could use the same drug -- atovaquone -- used to treat the malaria parasite when a person gets sick, coat mosquito bed nets with it, and let mosquitoes ingest the anti-malarial drug. The medication "cures" the mosquito, so it can't spread the disease.

How did they get the medicine into the mosquitoes? The researchers covered the bed nets with it. Childs' contribution to the research involved developing computer models that explored how adding atovaquone to the bed nets and its ability to cure individual mosquitoes affected malaria prevalence in the human population as a whole. Childs' modeling factored in various external conditions, such as the current malaria prevalence, bed net coverage, and level of insecticide resistance.

They found that mosquitoes that sat on the surfaces for six minutes -- a typical resting time on bed nets -- would absorb the medicine needed to kill the malaria parasite in them. The method could be more effective and less harmful to the people and environment in malaria hotspots. It has several advantages over the current techniques, Childs said.

"The mosquito should not develop resistance to the compounds because we're just killing the parasite that's inside it," she said. "And atovaquone is already a licensed drug, so we know it's safe for humans."

A resurgence of malaria due to insecticide resistance among Anopheles mosquitoes is a major threat. Though the U.S. Centers for Disease Control reported that deaths dropped by 25 percent from 2010 to 2016, nearly 450,000 people across the globe died of malaria in 2016. Many of the deaths were children in sub-Saharan Africa.

Developing, getting approval for, and distributing new insecticides to which mosquitoes have not built a resistance could take too long, as malaria illnesses and deaths spread. Childs credited her colleagues at Harvard's Chan School and the transdisciplinary team that melded her mathematical modeling skills with expertise in epidemiology, biology, public health, and other fields to offer a potential solution to a major global problem.

And it's a solution that could possibly be implemented in time to make a difference, she said.

"The population in sub-Saharan Africa is accustomed to bed nets and already uses them," Childs said. "There are a lot of reasons this could move quickly to action."
-end-


Virginia Tech

Related Malaria Articles:

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the Umeå University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.
Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.
New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.
Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.
Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.
Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.
Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.
Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.
The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.
Free malaria tests coupled with diagnosis-dependent vouchers for over-the-counter malaria treatment
Coupling free diagnostic tests for malaria with discounts on artemisinin combination therapy (ACT) when malaria is diagnosed can improve the rational use of ACTs and boost testing rates, according to a cluster-randomized trial published this week in PLOS Medicine by Wendy Prudhomme O'Meara of Duke University, USA, and colleagues.
More Malaria News and Malaria Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Meditations on Loneliness
Original broadcast date: April 24, 2020. We're a social species now living in isolation. But loneliness was a problem well before this era of social distancing. This hour, TED speakers explore how we can live and make peace with loneliness. Guests on the show include author and illustrator Jonny Sun, psychologist Susan Pinker, architect Grace Kim, and writer Suleika Jaouad.
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.